Online Database of Chemicals from Around the World Search | Submit | Advertise

Home >> Chemical Listing >> Apabetalone>> Market Analysis Reports
 

Market Analysis Reports of Apabetalone

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2017
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2017 SUMMARY Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) pipeline Target constitutes close to 38 molecules. Out of which approximately 28 molecules are developed ...

BET inhibitor - Pipeline Insight, 2022
... being developed by Constellation Pharmaceuticals. Apabetalone: Resverlogix Apabetalone is an entirely new epigenetic ... heart attacks and strokes. Apabetalone has a unique mechanism of action ... the BET family of proteins, apabetalone has the ability to normalize ...

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018 SUMMARY Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) pipeline Target constitutes close to 43 molecules. Out of which approximately 33 molecules are developed ...

Dyslipidaemia: KOL Insight
... the clinical programme for pradigastat? Apabetalone/RVX-208 (BET protein inhibitor ... ; Resverlogix): If approved, apabetalone is likely to be used in combination with other ...

Pulmonary Arterial Hypertension - Pipeline Insight, 2021
... Products MK-5475 Sotatercept LIQ861 GB-002 Apabetalone PB1046 L-606 CXA-10 GMA-301 ...

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) pipeline Target ...

Chronic Kidney Disease - Pipeline Review, H1 2017
Chronic Kidney Disease - Pipeline Review, H1 2017 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease - Pipeline Review, H1 2017, provides an overview of the Chronic Kidney Disease (Genito ...

Prediabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The 7 major prediabetes markets reached a value of US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 48.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.72% during 2024-2034. The prediabetes market has been ...

Vascular Dementia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The 7 major vascular dementia markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.89% during 2024-2034. The vascular dementia market has ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact